Introduction:Basic information about KURARINONE CAS 34981-26-5, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
KURARINONE Basic information
| Product Name: | KURARINONE |
| Synonyms: | KURARINONE;Kurarinon;Marini;4H-1-Benzopyran-4-one,2-(2,4-dihydroxyphenyl)-2,3-dihydro-7-hydroxy-5-methoxy-8-[(2R)-5-methyl-2-(1-methylethenyl)-4-hexen-1-yl]-,(2S)-;2-(2,4-Dihydroxyphenyl)-2,3-dihydro-7-hydroxy-5-methoxy-8-[5-methyl-2-(1-methylethenyl)-4-hexenyl]-4H-1-benzopyran-4-one;Kurarinone >=98% (HPLC);2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-8-(5-methyl-2-prop-1-en-2-ylhex-4-enyl)-2,3-dihydrochromen-4-one;(S)-2-(2,4-Dihydroxyphenyl)-7-hydroxy-5-methoxy-8-((R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl)chroman-4-one |
| CAS: | 34981-26-5 |
| MF: | C26H30O6 |
| MW: | 438.51 |
| EINECS: | 233-305-4 |
| Product Categories: | |
| Mol File: | 34981-26-5.mol |
|
KURARINONE Chemical Properties
| Melting point | 117-119℃ |
| Boiling point | 651.4±55.0 °C(Predicted) |
| density | 1?+-.0.06 g/cm3(Predicted) |
| storage temp. | -20°C |
| solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. |
| form | Powder |
| pka | 7.49±0.40(Predicted) |
| color | Light yellow to yellow |
| biological source | (isolated from Caragana sinica) |
| InChI | 1S/C25H28O6/c1-13(2)5-6-15(14(3)4)9-18-20(28)11-21(29)24-22(30)12-23(31-25(18)24)17-8-7-16(26)10-19(17)27/h5,7-8,10-11,15,23,26-29H,3,6,9,12H2,1-2,4H3 |
| InChIKey | XRYVAQQLDYTHCL-UHFFFAOYSA-N |
| SMILES | CC([C@H](CC=C(C)C)CC1=C2C(C(C[C@@H](C3=CC=C(O)C=C3O)O2)=O)=C(OC)C=C1O)=C |
Safety Information
| WGK Germany | WGK 3 |
| Storage Class | 11 - Combustible Solids |
KURARINONE Usage And Synthesis
| Uses | Kurarinone is an orally active flavonoid isolated from matrine that inhibits the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting cell differentiation of Th1 and Th17. Kurarinone has antitumor and anti-inflammatory activity[1][2][3]. |
| Definition | ChEBI: (2S)-(-)-kurarinone is a trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 7, 2' and 4', a lavandulyl group at position 8 and a methoxy group at position 5. Isolated from the roots of Sophora flavescens, it exhibits cytotoxicity against human myeloid leukemia HL-60 cells. It has a role as a metabolite and an antineoplastic agent. It is a trihydroxyflavanone, a monomethoxyflavanone and a member of 4'-hydroxyflavanones. It is functionally related to a (2S)-flavanone. |
| Biological Activity | Kurarinone, a flavonoid isolated from Sophora flavescens, inhibits the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting the differentiation of Th1 and Th17 cells. |
| Physiological effects | Kurarinon has an anti-endothelial cell proliferative activity, and it has a significant inhibitory effect on endothelial cell proliferation with a median inhibitory concentration (IC50) of 12ug/ml. |
| in vivo | Kurarinone (100 mg/kg, oral, days 21-42) has therapeutic effects in a collagen-induced arthritis (CIA) mouse model[3]. ? Kurarinone (100 mg/kg, po, from day 21-42) has a therapeutic effect in a mouse model of collagen-induced arthritis (CIA)[3].
| Animal Model: | CIA Mouse Model[3] | | Dosage: | 100 mg/kg | | Administration: | po | | Result: | Reduced the levels of proinflammatory cytokines, TNF-α, IL-6, IFN-γ, and IL-17A. Reduced STAT1 and STAT3 phosphorylation and the proportions of Th1 and Th17 cells in lymph nodes. |
|
| References | [1] Xie L, et al. The flavonoid kurarinone inhibits clinical progression of EAE through inhibiting Th1 and Th17 cell differentiation and proliferation. Int Immunopharmacol. 2018 Sep;62:227-236. DOI:10.1016/j.intimp.2018.06.022 [2] Nishikawa S, et al. Kurarinone from Sophora Flavescens Roots Triggers ATF4 Activation and Cytostatic Effects Through PERK Phosphorylation. Molecules. 2019 Aug 27;24(17):3110. DOI:10.3390/molecules24173110 [3] Tang KT, et al. Kurarinone Attenuates Collagen-Induced Arthritis in Mice by Inhibiting Th1/Th17 Cell Responses and Oxidative Stress. Int J Mol Sci. 2021 Apr 13;22(8):4002. DOI:10.3390/ijms22084002 |
KURARINONE Preparation Products And Raw materials